Table 1 Baseline characteristics for all patients
|  | IACT + RS | IVCT + RS | CCRT | p | χ2a |
|---|---|---|---|---|---|
Age (years) | 48.33±10.44 | 52.41±10.36 | 52.90±10.79 | 0.094 | - |
FIGO stage, n (%) | |||||
 IB2 | 13 (32.5%) | 17 (27.0%) | 20 (23.8%) | 0.888 | 1.138 |
 IIA2 | 19 (47.5%) | 31 (49.2%) | 43 (51.2%) |  |  |
 IIB | 8 (20.0%) | 15 (23.8%) | 21 (25.0%) |  |  |
Pathological type, n (%) | |||||
 Squamous cell carcinoma | 36 (90.0%) | 59 (93.7%) | 79 (94.0%) |  |  |
 Non-squamous cell carcinoma | 4 (10.0%) | 4 (6.3%) | 5 (6.0%) | 0.889 | 0.703 |
Differentiation, n (%) | |||||
 Well-differentiated and moderately differentiated | 31 (77.5%) | 52 (82.5%) | 67 (79.8%) | 0.411 | 0.814 |
 Poorly differentiated | 9 (22.5%) | 11 (17.5%) | 17 (20.2%) | ||